sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Apr-2014 13:34
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 501-525 out of 885.

<< < 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 > >>

Public Release: 15-Feb-2013
MSU launches groundbreaking drug trial in Africa
Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy each year.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University

Public Release: 15-Feb-2013
DNDi Latin America receives 2013 Carlos Slim Health Award
The Drugs for Neglected Diseases initiative in Latin America received the 2013 Carlos Slim Health Award in recognition of 10 years of exceptional work in research and development to deliver new, life-saving treatments for neglected patients.

Contact: Betina Moura
bmoura@dndi.org
55-218-122-4166
Drugs for Neglected Diseases Initiative

Public Release: 14-Feb-2013
Journal of Royal Society Interface
New methodology to predict pandemics
EcoHealth Alliance, the nonprofit organization that focuses on local conservation and global health issues, announced new research focused on the rapid identification of disease outbreaks in the peer reviewed publication, Journal of the Royal Society Interface.

Contact: Anthony M. Ramos
ramos@ecohealthalliance.org
212-380-4469
EcoHealth Alliance

Public Release: 13-Feb-2013
Cell Host & Microbe
Study suggests infant deaths can be prevented
An international team of tropical medicine researchers have discovered a potential method for preventing low birth weight in babies born to pregnant women who are exposed to malaria. Low birth weight is the leading cause of infant death globally.

Contact: June Pierotti
june.pierotti@uhn.ca
416-340-3895
University Health Network

Public Release: 13-Feb-2013
Tuberculosis and neglected diseases targeted by new center
A major new center to boost the development of drugs to tackle the foremost diseases of the developing world is to be created at the University of Dundee. The Centre is being established with joint funding from the Wellcome Trust and the Bill & Melinda Gates Foundation.
Wellcome Trust, Bill & Melinda Gates Foundation

Contact: Roddy Isles
r.isles@dundee.ac.uk
44-013-823-84910
University of Dundee

Public Release: 12-Feb-2013
Journal of American Chemical Society
Detecting cocaine 'naturally'
Since the beginning of time, living organisms have developed ingenious mechanisms to monitor their environment. As part of an international study, a team of researchers has adapted some of these natural mechanisms to detect specific molecules such as cocaine more accurately and quickly. Their work may greatly facilitate the rapid screening -- less than five minutes -- of many drugs, infectious diseases, and cancers.
Italian Ministry of University and Research, Bill & Melinda Gates Foundation, and others

Contact: Julie Gazaille
j.cordeau-gazaille@umontreal.ca
514-343-6796
University of Montreal

Public Release: 12-Feb-2013
24th Annual Conference of the Saudi Heart Association
CVD time bomb set to explode in Gulf region in 10-15 years
With one of the highest rates of obesity in the world, the Gulf region is facing an epidemic of cardiovascular disease. The Saudi Project for Assessment of Acute Coronary Syndrome found that 58 percent of the 5055 acute coronary syndrome patients in the study had diabetes.

Contact: Jacqueline Partarrieu
press@escardio.org
33-492-947-756
European Society of Cardiology

Public Release: 12-Feb-2013
PLOS Medicine
More evidence needed for scale up of mobile device technology in health
Despite the hundreds of pilot studies using mobile health -- also known as 'mHealth'', which describe medical and public health practice supported by mobile devices -- there is insufficient evidence to inform the widespread implementation and scale-up of this technology, according to international researchers writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
PLOS

Public Release: 12-Feb-2013
JAMA
Study examines malaria preventive therapy during pregnancy and outcomes for infants in Africa
Among pregnant women in sub-Saharan Africa, intermittent preventive therapy for malaria with 3 or more doses of the drug regimen sulfadoxine-pyrimethamine was associated with a higher birth weight and lower risk of low birth weight than the current standard 2-dose regimen, according to a review and meta-analysis of previous studies published in the Feb. 13 issue of JAMA.

Contact: Feiko O. ter Kuile
terkuile@liv.ac.uk
The JAMA Network Journals

Public Release: 11-Feb-2013
Diabetes Care
Community health workers help type 2 diabetes care
Researchers who conducted a clinical trial in American Samoa to test whether community health workers could help adults with type 2 diabetes found that the patients who received the intervention were twice as likely to make a clinically meaningful improvement as those who remained with care only in the clinic. The results appear in the journal Diabetes Care.
NIH/National Institute of Diabetes and Digestive and Kidney Disorders

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 11-Feb-2013
Proceedings of the National Academy of Sciences
Unchecked antibiotic use in animals may affect global human health
The increasing production and use of antibiotics, about half of which is used in animal production, is mirrored by the growing number of antibiotic resistance genes, or ARGs, effectively reducing antibiotics' ability to fend off diseases -- in animals and humans.

Contact: Layne Cameron
layne.cameron@cabs.msu.edu
517-353-8819
Michigan State University

Public Release: 8-Feb-2013
Genetics
Combining plasma screening methods better identifies diagnostic and therapeutic targets
For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases such as diabetes, cardiovascular disease or cancer, where blood plasma has been collected. This method could vastly improve a clinician's ability to identify disease susceptibility in individuals and populations.
Deutsche Forschungsgemeinschaft

Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America

Public Release: 7-Feb-2013
Interface
Surveillance system can identify and track emerging infectious diseases
A team of researchers developed a method to identify the cause of infectious disease outbreaks based on online reports about the symptoms, the season, and the ratio of cases to fatalities. Using data from the Internet outbreak reporting system ProMED-mail, the researchers applied this method to more than 100 outbreaks of encephalitis in South Asia, recently identified as an emerging infectious disease "hotspot," to determine which of 10 infectious diseases was causing symptoms of encephalitis
United States Agency for International Development

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 7-Feb-2013
First anti-tuberculosis medicine under USAID-supported PQM program achieves WHO prequalification
Helping to increase the availability of affordable, high-quality medicines to treat patients worldwide suffering from multi-drug resistant tuberculosis, technical assistance provided at no cost to manufacturers under the Promoting the Quality of Medicines program -- a U.S. Agency for International Development-funded program that is implemented by the U.S. Pharmacopeial Convention -- has yielded its first anti-tuberculosis medicine to achieve prequalification status from the World Health Organization.

Contact: Francine Pierson
fp@usp.org
301-816-8588
US Pharmacopeia

Public Release: 7-Feb-2013
Lancet Infectious Diseases
New study highlights Chagas disease as a growing health and socio-economic challenge
Today, The Lancet Infectious Diseases published a new report that examines the global economic burden of Chagas disease. In the first study of its kind, researchers measured the health and economic impact of Chagas disease and found that the total economic burden of Chagas disease matches or exceeds that of many more well-known diseases such as rotavirus, Lyme disease and cervical cancer.
Bill & Melinda Gates Foundation, Models of Infectious Disease Agent Study

Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 6-Feb-2013
Has the 'Golden Age' of global health funding come to an end?
Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to the Institute for Health Metrics and Evaluation at the University of Washington. After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011.
Bill & Melinda Gates Foundation

Contact: Rhonda Stewart
stewartr@uw.edu
206-861-6684
Institute for Health Metrics and Evaluation

Public Release: 6-Feb-2013
New England Journal of Medicine
Antibiotic cream has high cure rate, few side effects in treating cutaneous leishmaniasis
An international collaboration of researchers from the US Army Medical Research and Materiel Command, Tunisia and France has demonstrated a high cure rate and remarkably few side effects in treating patients with cutaneous leishmaniasis (CL) with an investigational antibiotic cream. CL is a parasitic disease that causes disfiguring lesions, with 350 million people at risk worldwide and 1.5 million new cases annually. The results were published today in the New England Journal of Medicine.
US Army Medical Research and Materiel Command

Contact: Carey Phillips
carey.a.phillips@amedd.army.mil
301-619-7056
US Army Medical Research Institute of Infectious Diseases

Public Release: 5-Feb-2013
Human bacteria sequencing project involving CU raises $340,000 online
In hopes of better understanding nutrition and health, the University of Colorado Boulder is playing the leading science role in a "crowdfunding" effort that has raised more than $340,000 for a project designed to sequence the gut bacteria of thousands of people around the world.
American Gut Project

Contact: Rob Knight
Rob.Knight@colorado.edu
303-492-1984
University of Colorado at Boulder

Public Release: 5-Feb-2013
Cell Metabolism
Scientists discover protein that allows safe recycling of iron from old red blood cells
Scientists have long hypothesized that our bodies must have a special protein 'container' for transporting heme -- the form of iron found in living things -- during the breakdown and recycling of old red cells and other types of heme metabolism. Now a research team led by scientists from the University of Maryland have identified this long-sought heme-iron transporter and shown that it is the same HRG1 protein found in a common microscopic worm.
National Institutes of Health

Contact: Lee Tune
ltune@umd.edu
301-405-4679
University of Maryland

Public Release: 4-Feb-2013
Proceedings of the National Academy of Sciences
Injection-free vaccination technique could address global vaccine challenge for HIV, malaria
Scientists at King's College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialized immune cells in the skin to kick-start the immunizing properties of the vaccine.
Bill & Melinda Gates Foundation

Contact: Katherine Barnes
katherine.barnes@kcl.ac.uk
44-207-848-3076
King's College London

Public Release: 1-Feb-2013
The FASEB Journal
Genetically modified tobacco plants produce antibodies to treat rabies
Smoking tobacco is bad for your health, but a genetically altered version of the plant might provide an inexpensive cure for the deadly rabies virus. In a new report in The FASEB Journal, scientists produced a monoclonal antibody in transgenic tobacco plants shown to neutralize the rabies virus. This antibody works by preventing the virus from attaching to nerve endings around the bite site and keeping the virus from traveling to the brain.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 31-Jan-2013
PLOS ONE
UCSB anthropologists study effects of modernization on physical activity and heart disease
Heart disease continues to be the leading cause of death in the United States, and a sedentary lifestyle is often cited as a major contributing factor. Among the Tsimane, an indigenous population in the lowlands of Bolivia's Amazon basin, however, indicators of heart disease are practically non-existent –– cholesterol is low, obesity is rare, and smoking is uncommon.

Contact: Andrea Estrada
andrea.estrada@ia.ucsb.edu
805-893-4620
University of California - Santa Barbara

Public Release: 31-Jan-2013
PLOS Pathogens
Placental blood flow can influence malaria during pregnancy
Malaria in pregnancy causes a range of adverse effects, including abortions and stillbirths. In the latest issue of the journal PLOS Pathogen, researchers from the Instituto Gulbenkian de Ciência, Portugal, observed, for the first time, the mouse placental circulation and showed how it can influence the malaria parasite behavior and infection. Their results indicate a higher accumulation of parasites in placental regions with low blood flow, being these areas more prone to an inflammatory response.
Fundação para a Ciência e a Tecnologia

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 31-Jan-2013
PLOS Neglected Tropical Diseases
African Programme for Onchocerciasis Control 1995-2015: Model-estimated health impact and cost
A relatively inexpensive program set up to combat river blindness has resulted in major health improvements in Africa, shows a study conducted by Erasmus University Medical Center researchers. The study, due to be published Jan. 31 in PLOS Neglected Tropical Diseases, shows that US $250 million helped cure or prevent the major symptoms of onchocerciasis in millions of people. In collaboration with the Management of the African Programme for Onchocerciasis Control (APOC), the researchers calculated the health impact of APOC.

Contact: Matthew Lopez
mlopez@plos.org
415-568-3174
PLOS

Public Release: 30-Jan-2013
Stem Cells Translational Medicine
'Petri dish lens' gives hope for new eye treatments
A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.
Australian Research Council

Contact: Emily Walker
emily.walker@monash.edu
61-399-034-844
Monash University

Showing releases 501-525 out of 885.

<< < 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 > >>